There is currently no reliable evidence showing that one particular breast implant brand is removed more often than others specifically because of breast implant illness (BII). Systemic symptoms that patients associate with BII have been reported with different types of breast implants, including both saline- and silicone-filled devices. The FDA continues to study these symptoms, which may include fatigue, brain fog, joint or muscle pain, and other systemic complaints. Some women report improvement after their implants are removed, but the relationship between breast implants and these symptoms is still not completely understood, and BII is not currently considered a formal medical diagnosis with a specific diagnostic test. It is also important to separate BII from known implant-specific complications such as rupture, capsular contracture, and BIA-ALCL. Therefore, I would not recommend choosing or avoiding an implant based simply on claims that one brand causes more BII. Implant selection should be individualized after discussing the available safety data, implant characteristics, and your goals with a board-certified plastic surgeon.